https://pharmadog.xyz/news/274135 pharmadog en 2026-08-18T16:26:00.000Z Biden-era law, not Trump, drives 2026 drop in brand-drug list prices https://pharmadog.xyz/news/273923 pharmadog en 2026-08-18T15:50:00.000Z BioMarin to buy Alesta Therapeutics for $275M, adding rare bone disease drug to pipeline https://pharmadog.xyz/news/273859 pharmadog en 2026-08-18T15:25:03.000Z Epic is under pressure https://pharmadog.xyz/news/273815 pharmadog en 2026-08-18T15:13:00.000Z AstraZeneca’s Tagrisso plus Orpathys improves survival in MET-mutated lung cancer https://pharmadog.xyz/news/273643 pharmadog en 2026-08-18T15:02:50.000Z BioMarin signs new deal for early-stage bone disease asset https://pharmadog.xyz/news/273925 pharmadog en 2026-08-18T14:38:00.000Z Leo Pharma buys rare skin disease drug in $435M deal https://pharmadog.xyz/news/273579 pharmadog en 2026-08-18T14:36:41.000Z STAT+: Government workers feel the squeeze on health care https://pharmadog.xyz/news/273535 pharmadog en 2026-08-18T14:25:50.000Z Exclusive: Third death revealed in China's popular but opaque trials https://pharmadog.xyz/news/273991 pharmadog en 2026-08-18T14:10:03.000Z FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices https://pharmadog.xyz/news/134233 pharmadog en 2026-08-18T14:02:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/273283 pharmadog en 2026-08-18T13:33:11.000Z Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars https://pharmadog.xyz/news/273303 pharmadog en 2026-08-18T13:25:37.000Z Eyepoint’s Phase 3 trial for age‑related blindness treatment fails primary endpoint, jeopardizing approval plans https://pharmadog.xyz/news/273284 pharmadog en 2026-08-18T13:09:39.000Z LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drug https://pharmadog.xyz/news/273176 pharmadog en 2026-08-18T13:02:37.000Z Kindergarten vaccine exemptions rise as Doritos marketing sparks food-health debate https://pharmadog.xyz/news/273177 pharmadog en 2026-08-18T13:00:00.000Z GenBio AI launches AIDO Cell, a virtual model that simulates whole-cell behavior https://pharmadog.xyz/news/273087 pharmadog en 2026-08-18T12:37:45.000Z Biotech funding rebound set to boost CDMO demand by early 2027 https://pharmadog.xyz/news/273286 pharmadog en 2026-08-18T11:23:52.000Z Regeneron ends eye disease study due to antibody's safety profile https://pharmadog.xyz/news/272703 pharmadog en 2026-08-18T11:23:52.000Z Regeneron halts Phase 1/2 uveitis antibody trial over unfavorable risk-benefit profile https://pharmadog.xyz/news/272635 pharmadog en 2026-08-18T11:02:00.000Z Amylyx reports avexitide cuts severe hypoglycemia by 55% in bariatric surgery patients https://pharmadog.xyz/news/272488 pharmadog en 2026-08-18T11:01:54.000Z Amylyx reports Phase 3 success for avexitide in post-bariatric hypoglycemia https://pharmadog.xyz/news/272595 pharmadog en 2026-08-18T11:01:00.000Z Amylyx to seek FDA approval for avexitide after Phase 3 success in post-bariatric hypoglycemia https://pharmadog.xyz/news/272532 pharmadog en 2026-08-18T11:01:00.000Z Amylyx avexitide cuts serious low blood sugar events by 55% in Phase 3 trial for post bariatric hypoglycemia https://pharmadog.xyz/news/272251 pharmadog en 2026-08-18T10:00:00.000Z Enveda reports promising Phase 1 data for oral drug that mimics exercise to preserve muscle during weight loss https://pharmadog.xyz/news/273236 pharmadog en 2026-08-18T09:15:00.000Z BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZeneca https://pharmadog.xyz/news/271801 pharmadog en 2026-08-18T08:30:00.000Z Study shows antibiotic overuse is concentrated in high-income nations, while low-income countries struggle with shortages https://pharmadog.xyz/news/271799 pharmadog en 2026-08-18T08:30:00.000Z STAT+: Doritos as farm-to-table snacks? Big Food, under duress, gets creative https://pharmadog.xyz/news/271800 pharmadog en 2026-08-18T08:30:00.000Z Opinion warns US surrogacy system is chaotic and may face bans after decades of legal battles https://pharmadog.xyz/news/271802 pharmadog en 2026-08-18T08:30:00.000Z Rising health-care costs force Pennsylvania county to raise property taxes by 22% https://pharmadog.xyz/news/273510 pharmadog en 2026-08-18T08:14:00.000Z Craif raises $33M to boost work on its urine test for cancer https://pharmadog.xyz/news/273234 pharmadog en 2026-08-18T07:53:00.000Z Johnson & Johnson MedTech nabs Monarch Quest 3 update for lung cancer detection https://pharmadog.xyz/news/271263 pharmadog en 2026-08-18T07:00:16.000Z Leo Pharma to license Tanabe’s oral drug for rare light-sensitive skin disease, paying up to $435 million https://pharmadog.xyz/news/270687 pharmadog en 2026-08-18T04:12:00.000Z AI and data sharing essential for safer cell and gene therapies, says industry leader https://pharmadog.xyz/news/270117 pharmadog en 2026-08-18T00:02:00.000Z L-Nutra recalls Prolon Apulian Almond & Cocoa Spread due to undeclared cashews, pistachios, hazelnuts https://pharmadog.xyz/news/273825 pharmadog en 2026-08-18T00:00:00.000Z Study highlights limits of premarket evaluation for identifying recalls of high-risk medical devices https://pharmadog.xyz/news/268425 pharmadog en 2026-08-17T21:55:00.000Z Oma's Pride recalls one lot of 6 lb Woof Complete canine chicken food after Salmonella contamination https://pharmadog.xyz/news/268479 pharmadog en 2026-08-17T20:20:28.000Z Experts say AI could outperform doctors on basic tasks by 2030 https://pharmadog.xyz/news/268130 pharmadog en 2026-08-17T19:23:54.000Z Sanofi to cut 229 Massachusetts jobs a year after $9.1 billion Blueprint Medicines acquisition https://pharmadog.xyz/news/268131 pharmadog en 2026-08-17T18:45:42.000Z Eyepoint's wet AMD therapy misses primary goal in Phase 3, stock tumbles https://pharmadog.xyz/news/272438 pharmadog en 2026-08-17T18:37:00.000Z Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win https://pharmadog.xyz/news/267526 pharmadog en 2026-08-17T17:28:00.000Z Drugmakers Back US Probe into Germany’s New Drug Pricing Policies https://pharmadog.xyz/news/267255 pharmadog en 2026-08-17T16:12:00.000Z Argenx reports positive Phase 3 results for Vyvgart Hytrulo in myositis https://pharmadog.xyz/news/266935 pharmadog en 2026-08-17T15:38:40.000Z EyePoint’s Phase 3 eye drug falls short of Eylea, stock tumbles 70% https://pharmadog.xyz/news/267132 pharmadog en 2026-08-17T15:31:00.000Z EyePoint shares tumble as Durayvu misses primary goal in wet AMD trial https://pharmadog.xyz/news/267257 pharmadog en 2026-08-17T15:13:00.000Z AstraZeneca halts Phase 3 lung cancer trial of bispecific antibody volrustomig after interim data miss survival goal https://pharmadog.xyz/news/266936 pharmadog en 2026-08-17T15:12:10.000Z Biotech raises $820M to bring China-sourced immunology drug to market via reverse merger https://pharmadog.xyz/news/266744 pharmadog en 2026-08-17T14:53:46.000Z AstraZeneca reports positive late-stage results for Tagrisso-Orpathys combo and Enhertu in lung cancer https://pharmadog.xyz/news/266745 pharmadog en 2026-08-17T14:48:39.000Z Summit and Akeso's ivonescimab wins Chinese first-line lung cancer approval, but longer follow-up shows reduced benefit https://pharmadog.xyz/news/266788 pharmadog en 2026-08-17T14:40:47.000Z IRS probes UnitedHealth tax filings and private-equity deals for doctor groups slow down https://pharmadog.xyz/news/266768 pharmadog en 2026-08-17T14:40:39.000Z EyePoint’s Phase 3 trial of duravyu fails to outperform aflibercept, shares plunge 70% https://pharmadog.xyz/news/266746 pharmadog en 2026-08-17T14:36:05.000Z Eli Lilly signs up to $370 million ion-channel collaboration with OmniAb https://pharmadog.xyz/news/267258 pharmadog en 2026-08-17T14:23:40.000Z Slate Medicines to merge with Fulcrum Therapeutics after Fulcrum drops sickle-cell drug https://pharmadog.xyz/news/266627 pharmadog en 2026-08-17T14:10:28.000Z Summit Therapeutics and Akeso celebrate third China approval for ivonescimab as new data show waning survival benefit https://pharmadog.xyz/news/267894 pharmadog en 2026-08-17T13:55:00.000Z Regeneron halts Phase 1/2a uveitis trial of anti-CD3 antibody after safety event https://pharmadog.xyz/news/266379 pharmadog en 2026-08-17T13:38:15.000Z Akeso and Summit’s lung cancer candidate shows worsening tumor progression, while Europe halts Tavneos over trial concerns https://pharmadog.xyz/news/266380 pharmadog en 2026-08-17T13:22:17.000Z AstraZeneca halts late-stage trial of volrustomig in metastatic lung cancer https://pharmadog.xyz/news/266335 pharmadog en 2026-08-17T13:19:34.000Z Celcuity waits on FDA review of second plant as cancer drug rollout lags expectations https://pharmadog.xyz/news/267501 pharmadog en 2026-08-17T13:06:00.000Z Merck KGaA's US research site to cut 20 jobs amid broader R&D downsizing https://pharmadog.xyz/news/266192 pharmadog en 2026-08-17T12:11:57.000Z AstraZeneca halts late-stage lung cancer trial of volrustomig after disappointing interim results https://pharmadog.xyz/news/273292 pharmadog en 2026-08-17T12:11:57.000Z AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blow https://pharmadog.xyz/news/266015 pharmadog en 2026-08-17T12:03:57.000Z Trump administration issues executive order overhauling federal vaccine program, drawing WHO criticism https://pharmadog.xyz/news/265995 pharmadog en 2026-08-17T12:02:43.000Z Vera Therapeutics receives FDA accelerated approval for Trutakna, an IgA nephropathy drug showing promising kidney function stabilization https://pharmadog.xyz/news/265867 pharmadog en 2026-08-17T11:39:30.000Z J&J returns rights to lymphoma CAR‑T therapy prizlon‑cel to AbelZeta https://pharmadog.xyz/news/265539 pharmadog en 2026-08-17T10:51:24.000Z Argenx reports Phase 3 success for Vyvgart Hytrulo in autoimmune myositis, despite subgroup shortfall https://pharmadog.xyz/news/265540 pharmadog en 2026-08-17T10:47:39.000Z AstraZeneca halts Phase 3 lung cancer trial of volrustomig after negative results https://pharmadog.xyz/news/266694 pharmadog en 2026-08-17T09:31:00.000Z Slate Medicines secures $245M financing and Nasdaq listing via reverse merger with Fulcrum Therapeutics https://pharmadog.xyz/news/266577 pharmadog en 2026-08-17T09:20:00.000Z Evaxion drops solid tumor vaccine program to prioritize brain cancer vaccine candidate https://pharmadog.xyz/news/265053 pharmadog en 2026-08-17T08:30:00.000Z IRS launches probe into UnitedHealth over alleged tax avoidance from 2017-2020 https://pharmadog.xyz/news/265056 pharmadog en 2026-08-17T08:30:00.000Z Paid paternity leave framed as preventive pediatric care in new opinion piece https://pharmadog.xyz/news/265055 pharmadog en 2026-08-17T08:30:00.000Z North Carolina’s bipartisan Medicaid pilot shows social services can cut health costs https://pharmadog.xyz/news/265054 pharmadog en 2026-08-17T08:30:00.000Z Epic faces antitrust lawsuits and internal AI strategy turmoil ahead of annual user meeting https://pharmadog.xyz/news/265052 pharmadog en 2026-08-17T08:30:00.000Z RFK Jr. contrasts vaccine push in D.C. with addiction-treatment focus in California https://pharmadog.xyz/news/271454 pharmadog en 2026-08-17T08:24:00.000Z Leo Pharma signs $435 million deal with Tanabe for rare skin disease drug dersimelagon https://pharmadog.xyz/news/266096 pharmadog en 2026-08-17T07:53:00.000Z FDA clears Lantheus' Tauklarify PET imaging agent for Alzheimer’s tau detection https://pharmadog.xyz/news/266097 pharmadog en 2026-08-17T07:44:00.000Z Eli Lilly signs up to $370M ion-channel collaboration with OmniAb https://pharmadog.xyz/news/264471 pharmadog en 2026-08-17T07:00:00.000Z Italian biotech sector gains traction as venture capital and tech transfer improvements boost startups https://pharmadog.xyz/news/266094 pharmadog en 2026-08-17T06:38:00.000Z Baylor Genetics suffers cyberattack exposing patient and employee data https://pharmadog.xyz/news/263979 pharmadog en 2026-08-17T05:01:00.000Z How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and Medicine https://pharmadog.xyz/news/263743 pharmadog en 2026-08-17T04:01:00.000Z State Laws Cut Private-Equity Acquisitions of Physician Practice Management Firms in Half https://pharmadog.xyz/news/264914 pharmadog en 2026-08-17T04:01:00.000Z AstraZeneca halts phase 3 lung cancer trial of bispecific antibody volrustomig after it falls short of Keytruda https://pharmadog.xyz/news/272979 pharmadog en 2026-08-17T04:00:00.000Z Intraosseous Needle Set Recall: Becton Dickinson Removes Certain Intraosseous Vascular Access System Needle Sets https://pharmadog.xyz/news/270354 pharmadog en 2026-08-17T00:00:00.000Z FDA approves Zenbexus for multiple myeloma as NSAI looks to sell MDR notified body unit https://pharmadog.xyz/news/270353 pharmadog en 2026-08-17T00:00:00.000Z FDA releases first updated guidance in 27 years on container and closure systems for drugs and biologics https://pharmadog.xyz/news/270355 pharmadog en 2026-08-17T00:00:00.000Z Saudi FDA launches program to accelerate rare-disease drug development https://pharmadog.xyz/news/266901 pharmadog en 2026-08-17T00:00:00.000Z Experts suggest new safety framework to boost predictability of CNS toxicity assessments